PsA inhibits the development of bovine embryos through epigenetic and oxidative stress

Xin Ma1, Chenglin Zhan1, Panpan Ma1,2

  • 1College of Animal Science and Technology, Jilin Agricultural University, Changchun, Jilin, China.

Abstract

Insights

Psammaplin A (PsA) inhibits bovine embryo development by decreasing pluripotency gene expression and increasing oxidative stress. This suggests careful clinical application of PsA to avoid reproductive toxicity.

Area of Science:

  • Reproductive biology and developmental toxicology.
  • Epigenetics and its role in early development.
  • Histone deacetylase inhibitors (HDACi) and their effects on cellular processes.

Background:

  • Histone deacetylases (HDACs) regulate crucial processes like embryo development and tumor progression.
  • HDACs are frequently dysregulated in tumor cells and somatic cell nuclear transfer (SCNT) embryos.
  • Psammaplin A (PsA) is a potent HDAC inhibitor with potential therapeutic applications.

Purpose of the Study:

  • To investigate the impact of PsA on the preimplantation development of bovine parthenogenetic (PA) embryos.
  • To analyze the effects of PsA on key developmental genes and epigenetic modifications in bovine embryos.
  • To evaluate the potential reproductive toxicity of PsA.

Main Methods:

  • Treatment of approximately 2,400 bovine PA embryos with varying concentrations and durations of PsA.
  • Analysis of blastocyst formation rates.
  • Assessment of pluripotency gene (Nanog) expression.
  • Measurement of histone acetylation (H3K9), DNA methylation, reactive oxygen species (ROS) generation, mitochondrial membrane potential (MMP), and superoxide dismutase 1 (SOD1) activity.

Main Results:

  • PsA significantly reduced blastocyst formation rates in a dose- and time-dependent manner.
  • PsA decreased Nanog expression and inhibited HDAC1 and DNMT1.
  • PsA enhanced H3K9 acetylation, increased ROS generation, and decreased MMP and SOD1 activity, indicating oxidative stress.

Conclusions:

  • PsA inhibits bovine preimplantation PA embryo development, highlighting the need for caution in clinical applications to prevent reproductive toxicity.
  • The reproductive toxicity of PsA may be linked to increased oxidative stress in embryos.
  • Combining PsA with antioxidants like melatonin could be a viable strategy for clinical use, mitigating adverse effects.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
3.9K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K